If concerns about the spread of the Hantavirus or any similar virus increase, the stocks that are often likely to benefit are within 5 main sectors...

Vaccine and treatment companies
Testing and diagnostics companies
Protective equipment and mask companies
Disinfection and infection control companies
Sometimes rodent and pest control companies

Top U.S. stocks that may move with Hantavirus news:

SIGA Technologies (SIGA)
A company that owns the TPOXX treatment related to viruses similar to smallpox, and often gets involved in speculation during outbreaks.
Chimerix (CMRX)
An antiviral drug company that typically moves alongside outbreak and rare disease stocks.
Emergent BioSolutions (EBS)
Works in vaccines and biodefense, and was among the beneficiaries of smallpox news previously.
Quest Diagnostics (DGX)
One of the largest medical testing and diagnostics companies, and any increase in epidemic testing could support revenue.
Labcorp Holdings (LH)
A major competitor to Quest and benefits from the expansion of infectious disease testing.
Moderna (MRNA)
mRNA stocks often rise on speculation when there is any fear of a new outbreak due to the speed of vaccine development. Some investors are currently discussing this with Hantavirus.
BioNTech (BNTX)
The same idea as Moderna, associated with rapid vaccine platforms.
Alpha Pro Tech (APT)
A company that makes N95 masks and protective equipment, which began moving in a speculative manner with the latest Hantavirus news.
Lakeland Industries (LAKE)
Produces medical and industrial protective suits and equipment, and often benefits as infection concerns escalate...
#OilPriceRollerCoaster $HK50